Not content with taking on the respiratory syncytial virus (RSV) prevention market with its antibody-based therapy Beyfortus, AstraZeneca has agreed to buy US biotech Icosavax and its phase 3 ...

Pulendran serves or has served on the external immunology board of GSK and on the scientific advisory boards of Sanofi, Medicago Inc., Boehringer Ingelheim, PharmaJet Inc., Icosavax Inc. and Ed-Jen.

Pulendran serves or has served on the external immunology board of GSK and on the scientific advisory boards of Sanofi, Medicago Inc., Boehringer Ingelheim, PharmaJet Inc., Icosavax Inc. and Ed-Jen.

Pulendran serves or has served on the external immunology board of GSK and on the scientific advisory boards of Sanofi, Medicago Inc., Boehringer Ingelheim, PharmaJet Inc., Icosavax Inc. and Ed-Jen.

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. hMPV is now included as a routine target in diagnostic respiratory virus PCR kits that target RSV and ...

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.